Abbott india share price

• The company has shown a good profit growth of 21.0459759345302% for the Past 3 years. • Company has been maintaining healthy ROE of 28.3098826669177% over the past 3 years. • Company has been maintaining healthy ROCE of 38.1957806387755% over the past 3 years. • Company is virtually debt free. • Company has a healthy Interest coverage ratio of 57.5303664921466. • The company has an efficient Cash Conversion Cycle of -42.9917507127215 days. • Company has a healthy liquidity position with current ratio of 3.20235374296661. • The company has a good cash flow management; CFO/PAT stands at 1.00630389298829. • The company has a high promoter holding of 74.99%. Quarterly Result (All Figures in Cr.) PARTICULARS Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Net Sales 1254.75 1304.37 1379.48 1326.48 1343.08 Total Expenditure 961.2 1033.97 1036.18 1009.99 1062.96 Operating Profit 293.55 270.4 343.3 316.49 280.12 Other Income 21.32 26.36 33.53 39.94 49.64 Interest 5.14 4.22 3.97 3.79 4.01 Depreciation 17.43 17.35 17.47 17.81 17.34 Exceptional Items 0 0 0 0 0 Profit Before Tax 292.3 275.19 355.39 334.83 308.41 Tax 80.89 69.55 89.87 88 76.99 Profit After Tax 211.41 205.64 265.52 246.83 231.42 Adjusted EPS (Rs) 99.49 96.77 124.95 116.16 108.9 Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.) PARTICULARS Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Net Sales 3298.5 3678.6 4093.14 4310.02 4919.27 Total Expenditure 2775.1 3074.56 3336.96 3391.13 3831.74 Operating Profit 523.4 604.05 7...

• Home • Budget 2022 • Market • CaFE Invest • Commodities • IPO NEWS • IPOs • Economy • Tech • Auto • SME • Mobility • Industry • Banking & Finance • Technology • SME/Start-ups • Audio • Jobs • Education • Mutual Funds • Sports • Money • Insurance • Income Tax • Infrastructure • Railways • Aviation • Roadways • India • Lifestyle • Travel & Tourism • Health • Science • From The Print • International • Edits & Columns • Opinion • FE 360 • Politics • Economy • Personal Finance Print • Front Page • FE Insight • Fe@Campus • Brand Wagon • Todays Paper • ePaper • Photos • Videos • Infographics • Horoscope • archive • Digital Currency Abbott India Ltd. is a Public Limited Listed company incorporated on 22/08/1944 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24239MH1944PLC007330 and registration number is 007330. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 4919.27 Cr. and Equity Capital is Rs. 21.25 Cr. for the Year ended 31/03/2022.

Hvis du klikker på « Godta alle», vil vi og • å vise personlig tilpassede annonser og innhold basert på interesseprofiler • å måle effektiviteten til personlig tilpassede annonser og innhold • å utvikle og forbedre våre produkter og tjenester Hvis du ikke vil at vi og våre partnere skal bruke informasjonskapsler og personlige data til disse tilleggsformålene, kan du klikke på « Avvis alle». Hvis du vil tilpasse valgene dine, klikker du på « Administrer personverninnstillinger». Du kan endre valgene dine når som helst ved å klikke på koblingene «Innstillinger for personvern og informasjonskapsler» eller «Instrumentbord for personvern» på nettstedene og appene våre. Finn ut mer om hvordan vi bruker personopplysningene dine i

• • Invest • • • • • Stock Screener (i-Lens) • • Markets App • • • • • • • • Budget 2023 • • Invest • • Top Mutual Funds • • • • • • • • • Invest • • • My Watchlist • • • • • Invest • • • • • • • Invest • • • • • • • Invest • • • • Invest • • • • One Assist • • • • • • Invest • • • • • • • • • Real Estate Investment Trust • • • • • • • • • • Investonomics • • • • • • • • • • • • • • • • • • • • • • • • • • Abbott India is one of the fastest growing listed MNC pharma companies. It has outperformed the industry on a consistent basis in women’s health, GI, metabolic, pain, CNS among others. • The company’s top five brands - (Mixtard, Thyronorm, Novomix, Udiliv and Duphaston) together posted revenue CAGR of ~6.6% MAT, March 2019-22 • Abbott has 140+ brands in segments of women’s health, gastroenterology, metabolics, CNS, multi-specialty, vaccines & consumer health Abbott India’s numbers were strong on the back of 14.2% YoY growth in top five therapies (anti-diabetic, GI, VMN, anti-infective, CNS) according to MAT March 2022, IQVIA. • Sales were up 15% YoY to ₹ 1255 crore • EBITDA was at ₹ 294 crore, up 43% YoY with margins at 23.4% • Consequent PAT was at ₹ 211 crore (up 39% YoY) Description • Abbott India Limited is a pharmaceutical company and has a market capitalization of Rs. 40,158.27 crores as of 25th August 2021. The company has reported its revenue income from operations of Rs. 4,310 crores at the end of March 2021. The Bombay Stock Exchange (BSE) and National Stock Ex...

NAME P/E (x) P/B (x) ROE % ROCE % ROA % Rev CAGR [3Yr] OPM NPM Basic EPS Current Ratio Total Debt/ Equity (x) Total Debt/ CFO (x) 50.21 14.95 29.77 38.50 20.84 9.26 24.11 17.75 446.78 2.51 0.00 0.00 38.88 13.63 35.07 41.95 18.35 0.49 25.80 18.78 36.05 2.04 0.00 0.00 28.18 19.51 33.24 22.93 27.21 2.62 28.27 40.85 100.38 5.04 0.00 0.00 27.92 12.53 48.64 55.14 29.95 -3.49 26.49 22.40 269.47 2.17 0.00 0.00 91.92 15.50 16.86 29.11 10.08 6.73 17.44 9.89 39.72 2.31 0.00 0.00 Add More • Stock Returns vs Nifty 100 Stock gave a 3 year return of 36.95% as compared to Nifty 100 which gave a return of 83.77%. (as of last trading session) • Stock Returns vs Nifty Pharma Stock generated 36.95% return as compared to Nifty Pharma which gave investors 30.16% return over 3 year time period. (as of last trading session) Meeting Date Announced on Purpose Details May 19, 2023 May 08, 2023 Board Meeting Audited Results & Final Dividend Feb 10, 2023 Jan 31, 2023 Board Meeting Quarterly Results Nov 14, 2022 Nov 03, 2022 Board Meeting Quarterly Results Aug 10, 2022 Jul 29, 2022 Board Meeting Quarterly Results Aug 10, 2022 May 17, 2022 AGM Book closure from 4 Aug, 2022 to 10 Aug, 2022 • All Types Ex-Date Record Date Announced on Details Bonus Aug 17, 1998 Sep 20, 1998 Aug 10, 1998 Bonus Ratio: 1 share(s) for every 1 shares held Rights - - Feb 02, 1994 Rights ratio: 1 share for every 10 held at a price of Rs 15.0 Bonus - - Jun 22, 1988 Bonus Ratio: 1 share(s) for every 1 shares held Bonus - Jul 28, 1...

Abbott India Ltd.: Share Price, Stock Analysis, Annual Report | Value Research Abbott India Ltd.: Share Price, Stock Analysis, Annual Report | Value Research https://www.valueresearchonline.com/stocks/40864/abbott-india-ltd/ Get Abbott India Ltd.'s stock analysis, price valuation, corporate actions, and financials from India's independent mutual fund research house. Business Abbott India Limited operates as a pharmaceutical company in India. It offers pharmaceutical products for various therapeutic areas, such as women's health, gastroenterology, metabolic, central nervous system, pain management, pre-term labor, vitamins, insomnia, vaccines, consumer health, etc. The company was formerly known as Knoll Pharmaceuticals Limited and changed its name to Abbott India Limited in July 2002. Abbott India Limited was incorporated in 1944 and is headquartered in Mumbai, India. Abbott India Limited is a subsidiary of Abbott Capital India Limited.